fanta.bio Sample: CNhs11961
18119 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1359 / 17967 (7.6%) | 396 / 179670 (0.2%) | −324.0 | −324.0 | 34.32 |
| TP53 SRX19538274 | U2OS Bone | 475 / 17967 (2.6%) | 159 / 179670 (0.1%) | −324.0 | −324.0 | 29.87 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1965 / 17967 (10.9%) | 725 / 179670 (0.4%) | −324.0 | −324.0 | 27.10 |
| TP53 SRX19538268 | U2OS Bone | 469 / 17967 (2.6%) | 176 / 179670 (0.1%) | −324.0 | −324.0 | 26.65 |
| HIF1A SRX11007095 | HK-2 Kidney | 2468 / 17967 (13.7%) | 932 / 179670 (0.5%) | −324.0 | −324.0 | 26.48 |
| TP53 SRX19538276 | U2OS Bone | 465 / 17967 (2.6%) | 176 / 179670 (0.1%) | −324.0 | −324.0 | 26.42 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1945 / 17967 (10.8%) | 746 / 179670 (0.4%) | −324.0 | −324.0 | 26.07 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 510 / 17967 (2.8%) | 206 / 179670 (0.1%) | −324.0 | −324.0 | 24.76 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2721 / 17967 (15.1%) | 1153 / 179670 (0.6%) | −324.0 | −324.0 | 23.60 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2645 / 17967 (14.7%) | 1122 / 179670 (0.6%) | −324.0 | −324.0 | 23.57 |
| FOXP1 SRX736067 | LNCAP Prostate | 2358 / 17967 (13.1%) | 1056 / 179670 (0.6%) | −324.0 | −324.0 | 22.33 |
| SCML2 SRX644728 | 293 Kidney | 1636 / 17967 (9.1%) | 747 / 179670 (0.4%) | −324.0 | −324.0 | 21.90 |
| TP53 SRX19538279 | Osteoblasts Bone | 580 / 17967 (3.2%) | 265 / 179670 (0.1%) | −324.0 | −324.0 | 21.89 |
| HIF1A SRX20663235 | HK-2 Kidney | 563 / 17967 (3.1%) | 258 / 179670 (0.1%) | −324.0 | −324.0 | 21.82 |
| MYH11 SRX265221 | ME-1 Blood | 1003 / 17967 (5.6%) | 605 / 179670 (0.3%) | −324.0 | −324.0 | 16.58 |
| MED1 SRX9419944 | BT-474 Breast | 3980 / 17967 (22.2%) | 2739 / 179670 (1.5%) | −324.0 | −324.0 | 14.53 |
| BRD4 SRX9419935 | BT-474 Breast | 4058 / 17967 (22.6%) | 2800 / 179670 (1.6%) | −324.0 | −324.0 | 14.49 |
| MED1 SRX9419945 | BT-474 Breast | 4068 / 17967 (22.6%) | 2809 / 179670 (1.6%) | −324.0 | −324.0 | 14.48 |
| BRD4 SRX9419937 | BT-474 Breast | 4032 / 17967 (22.4%) | 2830 / 179670 (1.6%) | −324.0 | −324.0 | 14.25 |
| MED1 SRX9419946 | BT-474 Breast | 4148 / 17967 (23.1%) | 2948 / 179670 (1.6%) | −324.0 | −324.0 | 14.07 |
| BRD4 SRX9419938 | BT-474 Breast | 4111 / 17967 (22.9%) | 2923 / 179670 (1.6%) | −324.0 | −324.0 | 14.06 |
| BRD4 SRX9419936 | BT-474 Breast | 4134 / 17967 (23.0%) | 2963 / 179670 (1.6%) | −324.0 | −324.0 | 13.95 |
| MED1 SRX9419947 | BT-474 Breast | 4016 / 17967 (22.4%) | 2880 / 179670 (1.6%) | −324.0 | −324.0 | 13.94 |
| EZH2 SRX2146136 | LNCAP Prostate | 9053 / 17967 (50.4%) | 8246 / 179670 (4.6%) | −324.0 | −324.0 | 10.98 |
| BRD4 SRX736201 | 90-8TL Neural | 6762 / 17967 (37.6%) | 6802 / 179670 (3.8%) | −324.0 | −324.0 | 9.94 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 839 / 17967 (4.7%) | 988 / 179670 (0.5%) | −324.0 | −324.0 | 8.49 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 783 / 17967 (4.4%) | 947 / 179670 (0.5%) | −324.0 | −324.0 | 8.27 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2023 / 17967 (11.3%) | 2702 / 179670 (1.5%) | −324.0 | −324.0 | 7.49 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1509 / 17967 (8.4%) | 3853 / 179670 (2.1%) | −324.0 | −324.0 | 3.92 |
| PBX4 SRX2731658 | PC-3 Prostate | 816 / 17967 (4.5%) | 28187 / 179670 (15.7%) | −324.0 | −324.0 | 0.29 |
| FOS SRX150478 | MCF 10A Breast | 603 / 17967 (3.4%) | 21687 / 179670 (12.1%) | −324.0 | −324.0 | 0.28 |
| FOS SRX150477 | MCF 10A Breast | 562 / 17967 (3.1%) | 21140 / 179670 (11.8%) | −324.0 | −324.0 | 0.27 |
| YAP1 SRX757325 | H2052 Lung | 578 / 17967 (3.2%) | 21905 / 179670 (12.2%) | −324.0 | −324.0 | 0.26 |
| YAP1 SRX757326 | H2052 Lung | 498 / 17967 (2.8%) | 19648 / 179670 (10.9%) | −324.0 | −324.0 | 0.25 |
| TP53 SRX19538267 | U2OS Bone | 428 / 17967 (2.4%) | 142 / 179670 (0.1%) | −315.9 | −312.9 | 30.14 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1704 / 17967 (9.5%) | 5458 / 179670 (3.0%) | −311.2 | −308.3 | 3.12 |
| TP53 SRX19538280 | Osteoblasts Bone | 460 / 17967 (2.6%) | 209 / 179670 (0.1%) | −310.9 | −307.9 | 22.01 |
| AGO2 SRX4708039 | Hep G2 Liver | 2110 / 17967 (11.7%) | 7855 / 179670 (4.4%) | −310.7 | −307.7 | 2.69 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 583 / 17967 (3.2%) | 20063 / 179670 (11.2%) | −310.5 | −307.6 | 0.29 |
| FOXA1 SRX4815198 | MCF-7 Breast | 967 / 17967 (5.4%) | 25732 / 179670 (14.3%) | −299.6 | −296.7 | 0.38 |
| FOS SRX4192880 | MCF 10A Breast | 441 / 17967 (2.5%) | 17244 / 179670 (9.6%) | −297.7 | −294.8 | 0.26 |
| TP53 SRX19538273 | U2OS Bone | 412 / 17967 (2.3%) | 153 / 179670 (0.1%) | −295.2 | −292.3 | 26.93 |
| TP53 SRX19538275 | U2OS Bone | 420 / 17967 (2.3%) | 168 / 179670 (0.1%) | −294.8 | −291.9 | 25.00 |
| TP53 SRX19538281 | Osteoblasts Bone | 478 / 17967 (2.7%) | 300 / 179670 (0.2%) | −288.7 | −285.8 | 15.93 |
| FOXA1 SRX4815197 | MCF-7 Breast | 692 / 17967 (3.9%) | 21115 / 179670 (11.8%) | −287.6 | −284.7 | 0.33 |
| Epitope tags SRX10549776 | K-562 Blood | 1642 / 17967 (9.1%) | 5435 / 179670 (3.0%) | −285.7 | −282.8 | 3.02 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1027 / 17967 (5.7%) | 25968 / 179670 (14.5%) | −280.9 | −278.0 | 0.40 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 690 / 17967 (3.8%) | 980 / 179670 (0.5%) | −272.9 | −270.1 | 7.04 |
| FOXA1 SRX176862 | MCF-7 Breast | 346 / 17967 (1.9%) | 14770 / 179670 (8.2%) | −271.9 | −269.0 | 0.23 |
| 5-mC SRX882970 | LNCAP Prostate | 3218 / 17967 (17.9%) | 16174 / 179670 (9.0%) | −269.7 | −266.9 | 1.99 |
| 5-mC SRX882968 | LNCAP Prostate | 3195 / 17967 (17.8%) | 16033 / 179670 (8.9%) | −268.5 | −265.7 | 1.99 |
| JUNB SRX8488088 | SUM 229PE Breast | 559 / 17967 (3.1%) | 18339 / 179670 (10.2%) | −268.0 | −265.2 | 0.30 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 706 / 17967 (3.9%) | 20667 / 179670 (11.5%) | −267.2 | −264.4 | 0.34 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 596 / 17967 (3.3%) | 695 / 179670 (0.4%) | −267.1 | −264.4 | 8.58 |
| ESR1 SRX7624157 | MCF-7 Breast | 784 / 17967 (4.4%) | 21833 / 179670 (12.2%) | −266.1 | −263.3 | 0.36 |
| IRF3 SRX11453858 | Hep G2 Liver | 333 / 17967 (1.9%) | 78 / 179670 (0.0%) | −265.7 | −263.0 | 42.69 |
| FOXA1 SRX176863 | MCF-7 Breast | 320 / 17967 (1.8%) | 14084 / 179670 (7.8%) | −264.8 | −262.0 | 0.23 |
| FOS SRX150517 | MCF 10A Breast | 499 / 17967 (2.8%) | 17141 / 179670 (9.5%) | −261.6 | −258.8 | 0.29 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1061 / 17967 (5.9%) | 25744 / 179670 (14.3%) | −260.7 | −258.0 | 0.41 |
| KAT7 SRX101303 | RKO Digestive tract | 1556 / 17967 (8.7%) | 5282 / 179670 (2.9%) | −260.3 | −257.5 | 2.95 |
| TP53 SRX19538269 | U2OS Bone | 501 / 17967 (2.8%) | 447 / 179670 (0.2%) | −259.4 | −256.7 | 11.21 |
| ESR1 SRX371478 | MCF-7 Breast | 364 / 17967 (2.0%) | 14665 / 179670 (8.2%) | −257.3 | −254.6 | 0.25 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1165 / 17967 (6.5%) | 27089 / 179670 (15.1%) | −257.1 | −254.3 | 0.43 |
| GATA3 SRX190239 | MCF-7 Breast | 424 / 17967 (2.4%) | 15633 / 179670 (8.7%) | −254.2 | −251.5 | 0.27 |
| ESR1 SRX4367193 | MCF-7 Breast | 1041 / 17967 (5.8%) | 25184 / 179670 (14.0%) | −253.1 | −250.4 | 0.41 |
| SS18 SRX3468047 | Fibroblasts Others | 791 / 17967 (4.4%) | 21454 / 179670 (11.9%) | −251.8 | −249.1 | 0.37 |
| BRD1 SRX286203 | RKO Digestive tract | 1353 / 17967 (7.5%) | 4248 / 179670 (2.4%) | −251.6 | −248.9 | 3.19 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 592 / 17967 (3.3%) | 754 / 179670 (0.4%) | −251.3 | −248.7 | 7.85 |
| YAP1 SRX5718140 | 293 Kidney | 497 / 17967 (2.8%) | 16772 / 179670 (9.3%) | −251.1 | −248.4 | 0.30 |
| TP53 SRX19538270 | U2OS Bone | 488 / 17967 (2.7%) | 444 / 179670 (0.2%) | −250.2 | −247.5 | 10.99 |
| ESR1 SRX20282961 | MCF-7 Breast | 363 / 17967 (2.0%) | 14418 / 179670 (8.0%) | −249.6 | −247.0 | 0.25 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 730 / 17967 (4.1%) | 20445 / 179670 (11.4%) | −249.6 | −246.9 | 0.36 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1278 / 17967 (7.1%) | 28345 / 179670 (15.8%) | −248.7 | −246.0 | 0.45 |
| AR SRX10820653 | LNCAP Prostate | 388 / 17967 (2.2%) | 207 / 179670 (0.1%) | −248.6 | −245.9 | 18.74 |
| TLE3 SRX4815191 | MCF-7 Breast | 257 / 17967 (1.4%) | 12387 / 179670 (6.9%) | −247.4 | −244.8 | 0.21 |
| FOXA1 SRX3931044 | MCF-7 Breast | 673 / 17967 (3.7%) | 19476 / 179670 (10.8%) | −247.0 | −244.3 | 0.35 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 770 / 17967 (4.3%) | 20886 / 179670 (11.6%) | −244.5 | −241.9 | 0.37 |
| FOXA1 SRX1161177 | MCF-7 Breast | 283 / 17967 (1.6%) | 12765 / 179670 (7.1%) | −243.3 | −240.7 | 0.22 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 339 / 17967 (1.9%) | 13774 / 179670 (7.7%) | −242.6 | −239.9 | 0.25 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 528 / 17967 (2.9%) | 17003 / 179670 (9.5%) | −242.3 | −239.6 | 0.31 |
| SMARCA2 SRX8119677 | MeT-5A Others | 490 / 17967 (2.7%) | 16376 / 179670 (9.1%) | −242.2 | −239.6 | 0.30 |
| GATA3 SRX190194 | SK-N-SH Neural | 759 / 17967 (4.2%) | 20628 / 179670 (11.5%) | −242.0 | −239.4 | 0.37 |
| FOS SRX150476 | MCF 10A Breast | 543 / 17967 (3.0%) | 17171 / 179670 (9.6%) | −239.9 | −237.3 | 0.32 |
| ESR1 SRX7624156 | MCF-7 Breast | 497 / 17967 (2.8%) | 16383 / 179670 (9.1%) | −238.8 | −236.2 | 0.30 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1065 / 17967 (5.9%) | 24952 / 179670 (13.9%) | −237.5 | −234.9 | 0.43 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 206 / 17967 (1.1%) | 11086 / 179670 (6.2%) | −237.0 | −234.4 | 0.19 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 351 / 17967 (2.0%) | 13804 / 179670 (7.7%) | −236.3 | −233.8 | 0.25 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 692 / 17967 (3.9%) | 19298 / 179670 (10.7%) | −233.1 | −230.5 | 0.36 |
| AR SRX1067070 | LHSAR Prostate | 805 / 17967 (4.5%) | 21005 / 179670 (11.7%) | −232.9 | −230.3 | 0.38 |
| BRPF3 SRX796085 | RKO Digestive tract | 1209 / 17967 (6.7%) | 3688 / 179670 (2.1%) | −232.9 | −230.3 | 3.28 |
| AR SRX1067071 | LHSAR Prostate | 634 / 17967 (3.5%) | 18389 / 179670 (10.2%) | −232.8 | −230.2 | 0.34 |
| 5-mC SRX882965 | LNCAP Prostate | 2587 / 17967 (14.4%) | 12498 / 179670 (7.0%) | −232.7 | −230.1 | 2.07 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 448 / 17967 (2.5%) | 15358 / 179670 (8.5%) | −232.3 | −229.8 | 0.29 |
| FOXA1 SRX371482 | MCF-7 Breast | 461 / 17967 (2.6%) | 15548 / 179670 (8.7%) | −231.5 | −229.0 | 0.30 |
| CEBPB SRX150632 | HeLa Uterus | 746 / 17967 (4.2%) | 20054 / 179670 (11.2%) | −231.1 | −228.6 | 0.37 |
| TP53 SRX19538282 | Osteoblasts Bone | 410 / 17967 (2.3%) | 305 / 179670 (0.2%) | −230.8 | −228.3 | 13.44 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 457 / 17967 (2.5%) | 15454 / 179670 (8.6%) | −230.6 | −228.1 | 0.30 |
| ESR1 SRX371469 | MCF-7 Breast | 318 / 17967 (1.8%) | 13027 / 179670 (7.3%) | −230.3 | −227.8 | 0.24 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 948 / 17967 (5.3%) | 2378 / 179670 (1.3%) | −229.8 | −227.3 | 3.99 |
| FOXA1 SRX1161176 | MCF-7 Breast | 282 / 17967 (1.6%) | 12350 / 179670 (6.9%) | −229.8 | −227.3 | 0.23 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 393 / 17967 (2.2%) | 14326 / 179670 (8.0%) | −229.4 | −226.9 | 0.27 |
| IRF3 SRX11453861 | Hep G2 Liver | 295 / 17967 (1.6%) | 81 / 179670 (0.0%) | −227.7 | −225.2 | 36.42 |
| ESR1 SRX176861 | MCF-7 Breast | 543 / 17967 (3.0%) | 16734 / 179670 (9.3%) | −226.6 | −224.1 | 0.32 |
| ESR1 SRX371476 | MCF-7 Breast | 208 / 17967 (1.2%) | 10806 / 179670 (6.0%) | −225.7 | −223.2 | 0.19 |
| ESR1 SRX176860 | MCF-7 Breast | 542 / 17967 (3.0%) | 16674 / 179670 (9.3%) | −225.2 | −222.7 | 0.33 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 734 / 17967 (4.1%) | 19652 / 179670 (10.9%) | −224.8 | −222.3 | 0.37 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 637 / 17967 (3.5%) | 18142 / 179670 (10.1%) | −224.1 | −221.6 | 0.35 |
| TCF12 SRX190356 | SK-N-SH Neural | 929 / 17967 (5.2%) | 22491 / 179670 (12.5%) | −223.7 | −221.2 | 0.41 |
| ESR1 SRX371471 | ZR-75-1 Breast | 340 / 17967 (1.9%) | 13196 / 179670 (7.3%) | −223.0 | −220.5 | 0.26 |
| ESR1 SRX371479 | MCF-7 Breast | 287 / 17967 (1.6%) | 12204 / 179670 (6.8%) | −221.8 | −219.4 | 0.24 |
| ESR1 SRX20282960 | MCF-7 Breast | 364 / 17967 (2.0%) | 13582 / 179670 (7.6%) | −221.6 | −219.2 | 0.27 |
| FOXA1 SRX371481 | MCF-7 Breast | 337 / 17967 (1.9%) | 13102 / 179670 (7.3%) | −221.6 | −219.1 | 0.26 |
| JUNB SRX8488073 | SUM 229PE Breast | 624 / 17967 (3.5%) | 17819 / 179670 (9.9%) | −220.7 | −218.2 | 0.35 |
| FOXA1 SRX371483 | MCF-7 Breast | 364 / 17967 (2.0%) | 13535 / 179670 (7.5%) | −220.1 | −217.7 | 0.27 |
| RUNX1 SRX2513054 | 293 Kidney | 3388 / 17967 (18.9%) | 18768 / 179670 (10.4%) | −219.9 | −217.5 | 1.81 |
| FOXA1 SRX1161173 | MCF-7 Breast | 234 / 17967 (1.3%) | 11116 / 179670 (6.2%) | −218.8 | −216.4 | 0.21 |
| FOXA1 SRX100454 | T-47D Breast | 412 / 17967 (2.3%) | 14319 / 179670 (8.0%) | −218.8 | −216.3 | 0.29 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 295 / 17967 (1.6%) | 12248 / 179670 (6.8%) | −218.4 | −215.9 | 0.24 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 428 / 17967 (2.4%) | 14563 / 179670 (8.1%) | −218.0 | −215.6 | 0.29 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 996 / 17967 (5.5%) | 23233 / 179670 (12.9%) | −217.7 | −215.3 | 0.43 |
| AR SRX10820651 | LNCAP Prostate | 398 / 17967 (2.2%) | 320 / 179670 (0.2%) | −216.4 | −214.0 | 12.44 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 576 / 17967 (3.2%) | 16892 / 179670 (9.4%) | −215.6 | −213.1 | 0.34 |
| ESR1 SRX371470 | ZR-75-1 Breast | 285 / 17967 (1.6%) | 11942 / 179670 (6.6%) | −214.3 | −211.9 | 0.24 |
| SMARCA4 SRX5212362 | Mel270 Others | 581 / 17967 (3.2%) | 16896 / 179670 (9.4%) | −213.3 | −210.9 | 0.34 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 425 / 17967 (2.4%) | 14355 / 179670 (8.0%) | −213.1 | −210.7 | 0.30 |
| BRPF3 SRX796084 | RKO Digestive tract | 1624 / 17967 (9.0%) | 6416 / 179670 (3.6%) | −212.8 | −210.4 | 2.53 |
| ESR1 SRX20282939 | MCF-7 Breast | 382 / 17967 (2.1%) | 13604 / 179670 (7.6%) | −212.4 | −210.0 | 0.28 |
| ESR1 SRX1531791 | MCF-7 Breast | 315 / 17967 (1.8%) | 12401 / 179670 (6.9%) | −211.5 | −209.1 | 0.25 |
| AGO2 SRX6783957 | Hep G2 Liver | 1342 / 17967 (7.5%) | 4724 / 179670 (2.6%) | −211.2 | −208.8 | 2.84 |
| FOS SRX4192879 | MCF 10A Breast | 375 / 17967 (2.1%) | 13428 / 179670 (7.5%) | −210.6 | −208.2 | 0.28 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1056 / 17967 (5.9%) | 23793 / 179670 (13.2%) | −210.3 | −207.9 | 0.44 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 558 / 17967 (3.1%) | 16417 / 179670 (9.1%) | −210.0 | −207.6 | 0.34 |
| ESR1 SRX194569 | MCF-7 Breast | 348 / 17967 (1.9%) | 12895 / 179670 (7.2%) | −208.6 | −206.2 | 0.27 |
| FOXA1 SRX1161175 | MCF-7 Breast | 230 / 17967 (1.3%) | 10731 / 179670 (6.0%) | −208.3 | −205.9 | 0.21 |
| SMARCA4 SRX5212366 | Mel270 Others | 449 / 17967 (2.5%) | 14563 / 179670 (8.1%) | −207.1 | −204.7 | 0.31 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 586 / 17967 (3.3%) | 971 / 179670 (0.5%) | −206.9 | −204.5 | 6.04 |
| JUN SRX17561461 | LPS141 Adipocyte | 499 / 17967 (2.8%) | 15355 / 179670 (8.5%) | −206.4 | −204.0 | 0.32 |
| ESR1 SRX371467 | MCF-7 Breast | 354 / 17967 (2.0%) | 12923 / 179670 (7.2%) | −206.1 | −203.7 | 0.27 |
| ARID1A SRX5089376 | MCF-7 Breast | 272 / 17967 (1.5%) | 11453 / 179670 (6.4%) | −206.0 | −203.7 | 0.24 |
| TP53 SRX19538271 | U2OS Bone | 668 / 17967 (3.7%) | 1307 / 179670 (0.7%) | −205.8 | −203.4 | 5.11 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1035 / 17967 (5.8%) | 23286 / 179670 (13.0%) | −204.8 | −202.4 | 0.44 |
| BRPF3 SRX796086 | RKO Digestive tract | 1548 / 17967 (8.6%) | 6083 / 179670 (3.4%) | −204.4 | −202.0 | 2.54 |
| GATA3 SRX176864 | MCF-7 Breast | 228 / 17967 (1.3%) | 10562 / 179670 (5.9%) | −203.8 | −201.4 | 0.22 |
| GATA3 SRX5057632 | MCF-7 Breast | 197 / 17967 (1.1%) | 9952 / 179670 (5.5%) | −203.7 | −201.3 | 0.20 |
| FOXA1 SRX1161174 | MCF-7 Breast | 338 / 17967 (1.9%) | 12558 / 179670 (7.0%) | −203.4 | −201.1 | 0.27 |
| VGLL1 SRX24602130 | BT-20 Breast | 346 / 17967 (1.9%) | 12698 / 179670 (7.1%) | −203.4 | −201.0 | 0.27 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 947 / 17967 (5.3%) | 21982 / 179670 (12.2%) | −203.1 | −200.8 | 0.43 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 364 / 17967 (2.0%) | 13000 / 179670 (7.2%) | −203.1 | −200.7 | 0.28 |
| EP300 SRX2194266 | SUM 159PT Breast | 601 / 17967 (3.3%) | 16848 / 179670 (9.4%) | −202.9 | −200.5 | 0.36 |
| ESR1 SRX194572 | MCF-7 Breast | 197 / 17967 (1.1%) | 9927 / 179670 (5.5%) | −202.7 | −200.4 | 0.20 |
| ESR1 SRX20282972 | MCF-7 Breast | 384 / 17967 (2.1%) | 13331 / 179670 (7.4%) | −202.6 | −200.3 | 0.29 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 893 / 17967 (5.0%) | 21174 / 179670 (11.8%) | −202.2 | −199.9 | 0.42 |
| BRD4 SRX736204 | 90-8TL Neural | 1009 / 17967 (5.6%) | 2991 / 179670 (1.7%) | −200.8 | −198.5 | 3.37 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 332 / 17967 (1.8%) | 12367 / 179670 (6.9%) | −200.6 | −198.2 | 0.27 |
| STAT3 SRX2020842 | HCC70 Breast | 620 / 17967 (3.5%) | 17048 / 179670 (9.5%) | −200.1 | −197.8 | 0.36 |
| EP300 SRX150579 | HeLa Uterus | 201 / 17967 (1.1%) | 9918 / 179670 (5.5%) | −199.6 | −197.3 | 0.20 |
| ESR1 SRX371468 | MCF-7 Breast | 204 / 17967 (1.1%) | 9966 / 179670 (5.5%) | −199.3 | −197.0 | 0.20 |
| SMARCA4 SRX5212357 | Mel270 Others | 502 / 17967 (2.8%) | 15163 / 179670 (8.4%) | −199.1 | −196.8 | 0.33 |
| ESR1 SRX20282954 | MCF-7 Breast | 380 / 17967 (2.1%) | 13144 / 179670 (7.3%) | −199.0 | −196.7 | 0.29 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 673 / 17967 (3.7%) | 1382 / 179670 (0.8%) | −198.5 | −196.2 | 4.87 |
| FOXA1 SRX371480 | MCF-7 Breast | 217 / 17967 (1.2%) | 10183 / 179670 (5.7%) | −198.1 | −195.8 | 0.21 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 304 / 17967 (1.7%) | 11795 / 179670 (6.6%) | −198.1 | −195.8 | 0.26 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 310 / 17967 (1.7%) | 11879 / 179670 (6.6%) | −197.5 | −195.2 | 0.26 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 252 / 17967 (1.4%) | 10789 / 179670 (6.0%) | −196.2 | −193.9 | 0.23 |
| JUN SRX4192884 | MCF 10A Breast | 274 / 17967 (1.5%) | 11174 / 179670 (6.2%) | −195.6 | −193.3 | 0.25 |
| ESR1 SRX10365535 | MCF-7 Breast | 269 / 17967 (1.5%) | 11077 / 179670 (6.2%) | −195.3 | −193.0 | 0.24 |
| ARID5B SRX3230377 | Hep G2 Liver | 910 / 17967 (5.1%) | 21145 / 179670 (11.8%) | −195.1 | −192.8 | 0.43 |
| ARID1A SRX5089379 | MCF-7 Breast | 330 / 17967 (1.8%) | 12152 / 179670 (6.8%) | −194.9 | −192.6 | 0.27 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 305 / 17967 (1.7%) | 11702 / 179670 (6.5%) | −194.6 | −192.3 | 0.26 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 320 / 17967 (1.8%) | 11964 / 179670 (6.7%) | −194.5 | −192.2 | 0.27 |
| AGO2 SRX6783958 | Hep G2 Liver | 1289 / 17967 (7.2%) | 4664 / 179670 (2.6%) | −194.1 | −191.8 | 2.76 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 297 / 17967 (1.7%) | 11543 / 179670 (6.4%) | −194.0 | −191.7 | 0.26 |
| FOXA2 SRX3230382 | Hep G2 Liver | 484 / 17967 (2.7%) | 14688 / 179670 (8.2%) | −193.7 | −191.4 | 0.33 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2134 / 17967 (11.9%) | 10199 / 179670 (5.7%) | −193.5 | −191.2 | 2.09 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 281 / 17967 (1.6%) | 120 / 179670 (0.1%) | −193.5 | −191.2 | 23.42 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 259 / 17967 (1.4%) | 10828 / 179670 (6.0%) | −193.3 | −191.0 | 0.24 |
| JUNB SRX8488089 | SUM 229PE Breast | 342 / 17967 (1.9%) | 12290 / 179670 (6.8%) | −192.6 | −190.3 | 0.28 |
| FOXA1 SRX1787653 | MCF-7 Breast | 276 / 17967 (1.5%) | 11092 / 179670 (6.2%) | −191.7 | −189.4 | 0.25 |
| SSRP1 SRX3436567 | HT-1080 Bone | 451 / 17967 (2.5%) | 573 / 179670 (0.3%) | −191.6 | −189.3 | 7.87 |
| TP53 SRX396254 | Fibroblasts Others | 957 / 17967 (5.3%) | 2826 / 179670 (1.6%) | −191.2 | −188.9 | 3.39 |
| ESR1 SRX371477 | MCF-7 Breast | 152 / 17967 (0.8%) | 8685 / 179670 (4.8%) | −191.0 | −188.8 | 0.18 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 643 / 17967 (3.6%) | 17076 / 179670 (9.5%) | −191.0 | −188.7 | 0.38 |
| WWTR1 SRX10119367 | MCF 10A Breast | 404 / 17967 (2.2%) | 13279 / 179670 (7.4%) | −190.7 | −188.4 | 0.30 |
| NR2F2 SRX190293 | MCF-7 Breast | 364 / 17967 (2.0%) | 12599 / 179670 (7.0%) | −190.5 | −188.2 | 0.29 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 332 / 17967 (1.8%) | 12044 / 179670 (6.7%) | −190.4 | −188.1 | 0.28 |
| FOXA2 SRX100448 | Hep G2 Liver | 391 / 17967 (2.2%) | 13048 / 179670 (7.3%) | −190.3 | −188.0 | 0.30 |
| ESR1 SRX10365536 | MCF-7 Breast | 167 / 17967 (0.9%) | 8961 / 179670 (5.0%) | −190.0 | −187.8 | 0.19 |
| STAT5B SRX831881 | CD8+ T cells Blood | 287 / 17967 (1.6%) | 139 / 179670 (0.1%) | −190.0 | −187.7 | 20.65 |
| RAC1 SRX10365541 | MCF-7 Breast | 167 / 17967 (0.9%) | 8958 / 179670 (5.0%) | −189.8 | −187.6 | 0.19 |
| JUNB SRX10119386 | MCF 10A Breast | 312 / 17967 (1.7%) | 11662 / 179670 (6.5%) | −189.4 | −187.1 | 0.27 |
| FOXA1 SRX3923514 | MCF-7 Breast | 358 / 17967 (2.0%) | 12455 / 179670 (6.9%) | −189.3 | −187.0 | 0.29 |
| RAC1 SRX10365543 | MCF-7 Breast | 167 / 17967 (0.9%) | 8939 / 179670 (5.0%) | −189.2 | −187.0 | 0.19 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 715 / 17967 (4.0%) | 18085 / 179670 (10.1%) | −189.0 | −186.8 | 0.40 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 321 / 17967 (1.8%) | 11796 / 179670 (6.6%) | −188.5 | −186.3 | 0.27 |
| WWTR1 SRX10119378 | MCF 10A Breast | 378 / 17967 (2.1%) | 12770 / 179670 (7.1%) | −188.5 | −186.3 | 0.30 |
| ESR1 SRX20282973 | MCF-7 Breast | 436 / 17967 (2.4%) | 13737 / 179670 (7.6%) | −188.5 | −186.3 | 0.32 |
| FOXA1 SRX11222441 | MCF-7 Breast | 260 / 17967 (1.4%) | 10676 / 179670 (5.9%) | −187.6 | −185.4 | 0.24 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 367 / 17967 (2.0%) | 12552 / 179670 (7.0%) | −187.5 | −185.3 | 0.29 |
| ESR1 SRX2943591 | MCF-7 Breast | 235 / 17967 (1.3%) | 10209 / 179670 (5.7%) | −187.5 | −185.3 | 0.23 |
| FOXA1 SRX11222437 | MCF-7 Breast | 240 / 17967 (1.3%) | 10285 / 179670 (5.7%) | −186.9 | −184.7 | 0.23 |
| JUN SRX6582171 | GM07492 Others | 720 / 17967 (4.0%) | 18081 / 179670 (10.1%) | −186.9 | −184.7 | 0.40 |
| Epitope tags SRX5877912 | U2OS Bone | 2162 / 17967 (12.0%) | 37141 / 179670 (20.7%) | −186.5 | −184.3 | 0.58 |
| SMARCA4 SRX5212371 | Mel270 Others | 517 / 17967 (2.9%) | 14967 / 179670 (8.3%) | −186.5 | −184.2 | 0.35 |
| AR SRX9469988 | LAPC-4 Prostate | 482 / 17967 (2.7%) | 14396 / 179670 (8.0%) | −186.0 | −183.8 | 0.33 |
| AR SRX1067067 | LHSAR Prostate | 629 / 17967 (3.5%) | 16674 / 179670 (9.3%) | −185.7 | −183.5 | 0.38 |
| CDK9 SRX7366783 | MCF-7 Breast | 278 / 17967 (1.5%) | 132 / 179670 (0.1%) | −185.2 | −183.0 | 21.06 |
| ING5 SRX286202 | RKO Digestive tract | 1386 / 17967 (7.7%) | 5397 / 179670 (3.0%) | −185.0 | −182.8 | 2.57 |
| TLE3 SRX4815192 | MCF-7 Breast | 317 / 17967 (1.8%) | 11590 / 179670 (6.5%) | −184.3 | −182.1 | 0.27 |
| TEAD1 SRX3401272 | MCF-7 Breast | 263 / 17967 (1.5%) | 10620 / 179670 (5.9%) | −183.9 | −181.7 | 0.25 |
| ESR1 SRX4367192 | MCF-7 Breast | 768 / 17967 (4.3%) | 18674 / 179670 (10.4%) | −183.9 | −181.7 | 0.41 |
| CEBPA SRX2630241 | Hep G2 Liver | 443 / 17967 (2.5%) | 13680 / 179670 (7.6%) | −183.5 | −181.3 | 0.32 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 857 / 17967 (4.8%) | 19939 / 179670 (11.1%) | −183.4 | −181.2 | 0.43 |
| JUNB SRX8488074 | SUM 229PE Breast | 489 / 17967 (2.7%) | 14419 / 179670 (8.0%) | −183.4 | −181.2 | 0.34 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1351 / 17967 (7.5%) | 26693 / 179670 (14.9%) | −183.1 | −180.9 | 0.51 |
| FOXA1 SRX11222442 | MCF-7 Breast | 223 / 17967 (1.2%) | 9851 / 179670 (5.5%) | −182.9 | −180.8 | 0.23 |
| ESR1 SRX2881002 | MCF-7 Breast | 339 / 17967 (1.9%) | 11927 / 179670 (6.6%) | −182.8 | −180.6 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 278 / 17967 (1.5%) | 10849 / 179670 (6.0%) | −182.6 | −180.4 | 0.26 |
| ESR1 SRX2881000 | MCF-7 Breast | 312 / 17967 (1.7%) | 11446 / 179670 (6.4%) | −182.5 | −180.3 | 0.27 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 642 / 17967 (3.6%) | 16754 / 179670 (9.3%) | −182.4 | −180.3 | 0.38 |
| EP300 SRX2194265 | SUM 159PT Breast | 576 / 17967 (3.2%) | 15745 / 179670 (8.8%) | −182.3 | −180.1 | 0.37 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 323 / 17967 (1.8%) | 11634 / 179670 (6.5%) | −182.3 | −180.1 | 0.28 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 328 / 17967 (1.8%) | 11718 / 179670 (6.5%) | −182.2 | −180.0 | 0.28 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 342 / 17967 (1.9%) | 11956 / 179670 (6.7%) | −182.1 | −179.9 | 0.29 |
| FOXA1 SRX3931043 | MCF-7 Breast | 365 / 17967 (2.0%) | 12344 / 179670 (6.9%) | −182.1 | −179.9 | 0.30 |
| FOXL2 SRX6957431 | KGN Gonad | 862 / 17967 (4.8%) | 19952 / 179670 (11.1%) | −181.9 | −179.7 | 0.43 |
| MEAF6 DRX300417 | 293 Kidney | 1616 / 17967 (9.0%) | 6923 / 179670 (3.9%) | −181.9 | −179.7 | 2.33 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 243 / 17967 (1.4%) | 10188 / 179670 (5.7%) | −181.8 | −179.7 | 0.24 |
| JUN SRX883584 | MDA-MB-231 Breast | 589 / 17967 (3.3%) | 15924 / 179670 (8.9%) | −181.8 | −179.6 | 0.37 |
| FOXA1 SRX100506 | Hep G2 Liver | 494 / 17967 (2.7%) | 14439 / 179670 (8.0%) | −181.7 | −179.5 | 0.34 |
| MEAF6 DRX234811 | 293 Kidney | 1756 / 17967 (9.8%) | 7863 / 179670 (4.4%) | −181.5 | −179.3 | 2.23 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 554 / 17967 (3.1%) | 15370 / 179670 (8.6%) | −181.4 | −179.2 | 0.36 |
| FOXA1 SRX5323843 | MCF-7 Breast | 163 / 17967 (0.9%) | 8635 / 179670 (4.8%) | −181.3 | −179.2 | 0.19 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 337 / 17967 (1.9%) | 11842 / 179670 (6.6%) | −181.3 | −179.1 | 0.28 |
| YAP1 SRX10119364 | MCF 10A Breast | 291 / 17967 (1.6%) | 11027 / 179670 (6.1%) | −180.8 | −178.7 | 0.26 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 739 / 17967 (4.1%) | 18123 / 179670 (10.1%) | −180.5 | −178.3 | 0.41 |
| ESR1 SRX20282955 | MCF-7 Breast | 392 / 17967 (2.2%) | 12736 / 179670 (7.1%) | −180.3 | −178.1 | 0.31 |
| STAT3 SRX150536 | MCF 10A Breast | 404 / 17967 (2.2%) | 12917 / 179670 (7.2%) | −179.7 | −177.6 | 0.31 |
| PBX3 SRX190343 | SK-N-SH Neural | 797 / 17967 (4.4%) | 18929 / 179670 (10.5%) | −179.5 | −177.4 | 0.42 |
| ESR1 SRX10365532 | MCF-7 Breast | 182 / 17967 (1.0%) | 8955 / 179670 (5.0%) | −179.3 | −177.1 | 0.20 |
| ESR1 SRX371475 | BT-474 Breast | 167 / 17967 (0.9%) | 8643 / 179670 (4.8%) | −178.8 | −176.7 | 0.19 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 655 / 17967 (3.6%) | 1460 / 179670 (0.8%) | −178.6 | −176.5 | 4.49 |
| EP300 SRX2671813 | Fibroblasts Others | 300 / 17967 (1.7%) | 11112 / 179670 (6.2%) | −178.5 | −176.3 | 0.27 |
| STAT3 SRX150479 | MCF 10A Breast | 340 / 17967 (1.9%) | 11793 / 179670 (6.6%) | −178.1 | −176.0 | 0.29 |
| JUN SRX6582172 | Fibroblasts Others | 494 / 17967 (2.7%) | 14311 / 179670 (8.0%) | −178.0 | −175.9 | 0.35 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 572 / 17967 (3.2%) | 15512 / 179670 (8.6%) | −177.6 | −175.5 | 0.37 |
| NKX2-1 SRX2164786 | A549 Lung | 615 / 17967 (3.4%) | 16165 / 179670 (9.0%) | −177.6 | −175.4 | 0.38 |
| ESR1 SRX330067 | MCF-7 Breast | 331 / 17967 (1.8%) | 11615 / 179670 (6.5%) | −177.5 | −175.3 | 0.28 |
| FOXA1 SRX028634 | MCF-7 Breast | 161 / 17967 (0.9%) | 8476 / 179670 (4.7%) | −177.3 | −175.2 | 0.19 |
| SOX13 SRX2636248 | Hep G2 Liver | 516 / 17967 (2.9%) | 14627 / 179670 (8.1%) | −177.0 | −174.9 | 0.35 |
| AR SRX1067066 | LHSAR Prostate | 806 / 17967 (4.5%) | 18964 / 179670 (10.6%) | −177.0 | −174.9 | 0.43 |
| CDK9 SRX7366781 | MCF-7 Breast | 262 / 17967 (1.5%) | 120 / 179670 (0.1%) | −176.6 | −174.5 | 21.83 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 673 / 17967 (3.7%) | 16995 / 179670 (9.5%) | −176.4 | −174.3 | 0.40 |
| PRRX1 SRX15235713 | Hs 578T Breast | 458 / 17967 (2.5%) | 13681 / 179670 (7.6%) | −176.4 | −174.3 | 0.33 |
| ESR1 SRX20282940 | MCF-7 Breast | 414 / 17967 (2.3%) | 12939 / 179670 (7.2%) | −175.5 | −173.4 | 0.32 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 402 / 17967 (2.2%) | 12742 / 179670 (7.1%) | −175.4 | −173.3 | 0.32 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 696 / 17967 (3.9%) | 17291 / 179670 (9.6%) | −175.2 | −173.1 | 0.40 |
| STAT3 SRX150630 | MCF 10A Breast | 340 / 17967 (1.9%) | 11693 / 179670 (6.5%) | −175.1 | −173.0 | 0.29 |
| NR3C1 SRX2609664 | HASM2 Lung | 535 / 17967 (3.0%) | 14831 / 179670 (8.3%) | −174.5 | −172.4 | 0.36 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 489 / 17967 (2.7%) | 14103 / 179670 (7.8%) | −174.2 | −172.1 | 0.35 |
| FOXA1 SRX3931054 | MCF-7 Breast | 344 / 17967 (1.9%) | 11718 / 179670 (6.5%) | −173.7 | −171.6 | 0.29 |
| CEBPB SRX2194250 | SUM 159PT Breast | 456 / 17967 (2.5%) | 13557 / 179670 (7.5%) | −173.6 | −171.5 | 0.34 |
| FOXA1 SRX1787655 | MCF-7 Breast | 169 / 17967 (0.9%) | 8530 / 179670 (4.7%) | −173.6 | −171.5 | 0.20 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 346 / 17967 (1.9%) | 11742 / 179670 (6.5%) | −173.5 | −171.4 | 0.29 |
| GATAD2A SRX2636506 | Hep G2 Liver | 488 / 17967 (2.7%) | 14057 / 179670 (7.8%) | −173.4 | −171.3 | 0.35 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 348 / 17967 (1.9%) | 11770 / 179670 (6.6%) | −173.3 | −171.2 | 0.30 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 742 / 17967 (4.1%) | 17896 / 179670 (10.0%) | −173.3 | −171.2 | 0.41 |
| LEO1 SRX1873456 | SEM Blood | 1509 / 17967 (8.4%) | 6389 / 179670 (3.6%) | −173.2 | −171.1 | 2.36 |
| FOXA1 SRX3931055 | MCF-7 Breast | 309 / 17967 (1.7%) | 11094 / 179670 (6.2%) | −172.9 | −170.9 | 0.28 |
| ARID5B SRX10475139 | Hep G2 Liver | 408 / 17967 (2.3%) | 12743 / 179670 (7.1%) | −172.5 | −170.4 | 0.32 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1405 / 17967 (7.8%) | 5742 / 179670 (3.2%) | −172.0 | −169.9 | 2.45 |
| AR SRX9109110 | MDA-MB-453 Breast | 727 / 17967 (4.0%) | 17623 / 179670 (9.8%) | −171.9 | −169.8 | 0.41 |
| FOXA1 SRX6878603 | LNCAP Prostate | 414 / 17967 (2.3%) | 12817 / 179670 (7.1%) | −171.9 | −169.8 | 0.32 |
| RELA SRX5938177 | FaDu Others | 344 / 17967 (1.9%) | 11651 / 179670 (6.5%) | −171.7 | −169.6 | 0.30 |
| KAT6A SRX20971022 | Fibroblasts Others | 245 / 17967 (1.4%) | 99 / 179670 (0.1%) | −171.5 | −169.4 | 24.75 |
| ESR1 SRX371474 | BT-474 Breast | 156 / 17967 (0.9%) | 8201 / 179670 (4.6%) | −171.2 | −169.1 | 0.19 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 553 / 17967 (3.1%) | 14990 / 179670 (8.3%) | −171.2 | −169.1 | 0.37 |
| NR3C1 SRX17639412 | A549 Lung | 421 / 17967 (2.3%) | 12906 / 179670 (7.2%) | −171.1 | −169.0 | 0.33 |
| BMI1 SRX644729 | 293 Kidney | 264 / 17967 (1.5%) | 137 / 179670 (0.1%) | −170.8 | −168.7 | 19.27 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 347 / 17967 (1.9%) | 11666 / 179670 (6.5%) | −170.6 | −168.5 | 0.30 |
| FOXA1 SRX1161203 | T-47D Breast | 261 / 17967 (1.5%) | 10154 / 179670 (5.7%) | −170.1 | −168.0 | 0.26 |
| RELA SRX7055007 | HAEC Cardiovascular | 709 / 17967 (3.9%) | 17283 / 179670 (9.6%) | −169.9 | −167.8 | 0.41 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 451 / 17967 (2.5%) | 13344 / 179670 (7.4%) | −169.8 | −167.8 | 0.34 |
| NFYB SRX16608147 | HeLa Uterus | 290 / 17967 (1.6%) | 197 / 179670 (0.1%) | −169.6 | −167.6 | 14.72 |
| ESR1 SRX330069 | MCF-7 Breast | 223 / 17967 (1.2%) | 9447 / 179670 (5.3%) | −169.6 | −167.5 | 0.24 |
| ESR1 SRX3110725 | MCF-7 Breast | 344 / 17967 (1.9%) | 11579 / 179670 (6.4%) | −169.4 | −167.3 | 0.30 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 526 / 17967 (2.9%) | 14512 / 179670 (8.1%) | −169.4 | −167.3 | 0.36 |
| FOSL2 SRX190296 | SK-N-SH Neural | 522 / 17967 (2.9%) | 14444 / 179670 (8.0%) | −169.2 | −167.2 | 0.36 |
| ESR1 SRX5323873 | MCF-7 Breast | 473 / 17967 (2.6%) | 13676 / 179670 (7.6%) | −169.2 | −167.1 | 0.35 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 329 / 17967 (1.8%) | 11310 / 179670 (6.3%) | −169.0 | −167.0 | 0.29 |
| Epitope tags DRX443510 | 293 Kidney | 1506 / 17967 (8.4%) | 6453 / 179670 (3.6%) | −168.9 | −166.8 | 2.33 |
| FOXA1 SRX190181 | A549 Lung | 261 / 17967 (1.5%) | 10119 / 179670 (5.6%) | −168.9 | −166.8 | 0.26 |
| CIC SRX13262055 | Astrocytes Neural | 3048 / 17967 (17.0%) | 17697 / 179670 (9.8%) | −168.7 | −166.7 | 1.72 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 304 / 17967 (1.7%) | 10869 / 179670 (6.0%) | −168.7 | −166.6 | 0.28 |
| FOXA1 SRX11222438 | MCF-7 Breast | 188 / 17967 (1.0%) | 8750 / 179670 (4.9%) | −168.5 | −166.4 | 0.21 |
| FOXA1 SRX1447317 | MCF-7 Breast | 235 / 17967 (1.3%) | 9629 / 179670 (5.4%) | −168.3 | −166.2 | 0.24 |
| ESR1 SRX8537722 | MCF-7 Breast | 355 / 17967 (2.0%) | 11726 / 179670 (6.5%) | −168.2 | −166.2 | 0.30 |
| FOXA1 SRX3923517 | MCF-7 Breast | 263 / 17967 (1.5%) | 10130 / 179670 (5.6%) | −168.2 | −166.1 | 0.26 |
| JUND SRX150408 | HeLa Uterus | 336 / 17967 (1.9%) | 11398 / 179670 (6.3%) | −168.1 | −166.0 | 0.29 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 172 / 17967 (1.0%) | 8425 / 179670 (4.7%) | −168.0 | −165.9 | 0.20 |
| FOXA1 SRX028635 | MCF-7 Breast | 173 / 17967 (1.0%) | 8442 / 179670 (4.7%) | −167.9 | −165.8 | 0.20 |
| FOXA1 SRX15430999 | T-47D Breast | 426 / 17967 (2.4%) | 12871 / 179670 (7.2%) | −167.7 | −165.7 | 0.33 |
| ESR1 SRX10365558 | MCF-7 Breast | 249 / 17967 (1.4%) | 9864 / 179670 (5.5%) | −167.7 | −165.6 | 0.25 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 391 / 17967 (2.2%) | 12298 / 179670 (6.8%) | −167.6 | −165.6 | 0.32 |
| FOSL2 SRX190204 | A549 Lung | 377 / 17967 (2.1%) | 12070 / 179670 (6.7%) | −167.6 | −165.6 | 0.31 |
| ARID1A SRX5089385 | MCF-7 Breast | 277 / 17967 (1.5%) | 10360 / 179670 (5.8%) | −167.6 | −165.5 | 0.27 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 926 / 17967 (5.2%) | 2944 / 179670 (1.6%) | −167.6 | −165.5 | 3.15 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1180 / 17967 (6.6%) | 4417 / 179670 (2.5%) | −167.5 | −165.5 | 2.67 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 559 / 17967 (3.1%) | 14954 / 179670 (8.3%) | −167.5 | −165.5 | 0.37 |
| ESR1 SRX20282946 | MCF-7 Breast | 222 / 17967 (1.2%) | 9357 / 179670 (5.2%) | −167.3 | −165.2 | 0.24 |
| FOXA1 SRX100477 | Hep G2 Liver | 444 / 17967 (2.5%) | 13145 / 179670 (7.3%) | −167.3 | −165.2 | 0.34 |
| EP300 SRX176885 | MCF-7 Breast | 186 / 17967 (1.0%) | 8676 / 179670 (4.8%) | −167.1 | −165.1 | 0.21 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 174 / 17967 (1.0%) | 8434 / 179670 (4.7%) | −167.0 | −165.0 | 0.21 |
| FOXA1 SRX1961157 | T-47D Breast | 412 / 17967 (2.3%) | 12611 / 179670 (7.0%) | −166.7 | −164.7 | 0.33 |
| FOXA1 SRX1787651 | MCF-7 Breast | 207 / 17967 (1.2%) | 9043 / 179670 (5.0%) | −166.2 | −164.2 | 0.23 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 237 / 17967 (1.3%) | 9595 / 179670 (5.3%) | −166.1 | −164.0 | 0.25 |
| Epitope tags SRX5877914 | U2OS Bone | 2218 / 17967 (12.3%) | 36828 / 179670 (20.5%) | −166.0 | −164.0 | 0.60 |
| ARID5B SRX10475138 | Hep G2 Liver | 657 / 17967 (3.7%) | 16348 / 179670 (9.1%) | −165.4 | −163.4 | 0.40 |
| ESR1 SRX2943589 | MCF-7 Breast | 187 / 17967 (1.0%) | 8636 / 179670 (4.8%) | −165.2 | −163.2 | 0.22 |
| ESR1 SRX330070 | MCF-7 Breast | 189 / 17967 (1.1%) | 8675 / 179670 (4.8%) | −165.2 | −163.1 | 0.22 |
| ESR1 SRX4451213 | MCF-7 Breast | 396 / 17967 (2.2%) | 12293 / 179670 (6.8%) | −165.0 | −163.0 | 0.32 |
| FOXA1 SRX1787652 | MCF-7 Breast | 230 / 17967 (1.3%) | 9430 / 179670 (5.2%) | −164.7 | −162.7 | 0.24 |
| FOXA1 SRX3923516 | MCF-7 Breast | 273 / 17967 (1.5%) | 10197 / 179670 (5.7%) | −164.5 | −162.5 | 0.27 |
| ESR1 SRX5323871 | MCF-7 Breast | 427 / 17967 (2.4%) | 12781 / 179670 (7.1%) | −164.5 | −162.5 | 0.33 |
| ESR1 SRX20282953 | MCF-7 Breast | 319 / 17967 (1.8%) | 10993 / 179670 (6.1%) | −164.5 | −162.5 | 0.29 |
| ESR1 SRX1531796 | MCF-7 Breast | 194 / 17967 (1.1%) | 8746 / 179670 (4.9%) | −164.4 | −162.4 | 0.22 |
| GFP SRX6949256 | HeLa Uterus | 430 / 17967 (2.4%) | 12820 / 179670 (7.1%) | −164.4 | −162.4 | 0.34 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 559 / 17967 (3.1%) | 14840 / 179670 (8.3%) | −164.4 | −162.3 | 0.38 |
| JUN SRX2355072 | HAEC Cardiovascular | 526 / 17967 (2.9%) | 14330 / 179670 (8.0%) | −164.3 | −162.3 | 0.37 |
| ESR1 SRX20282971 | MCF-7 Breast | 391 / 17967 (2.2%) | 12188 / 179670 (6.8%) | −164.3 | −162.3 | 0.32 |
| ESR1 SRX10365533 | MCF-7 Breast | 166 / 17967 (0.9%) | 8195 / 179670 (4.6%) | −164.1 | −162.1 | 0.20 |
| PROX1 SRX3230397 | Hep G2 Liver | 271 / 17967 (1.5%) | 10147 / 179670 (5.6%) | −164.1 | −162.1 | 0.27 |
| FOXA1 SRX3923518 | MCF-7 Breast | 261 / 17967 (1.5%) | 9959 / 179670 (5.5%) | −163.9 | −161.9 | 0.26 |
| Epitope tags SRX10549778 | K-562 Blood | 1151 / 17967 (6.4%) | 4300 / 179670 (2.4%) | −163.9 | −161.9 | 2.68 |
| JUND SRX190357 | SK-N-SH Neural | 507 / 17967 (2.8%) | 14009 / 179670 (7.8%) | −163.6 | −161.6 | 0.36 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 326 / 17967 (1.8%) | 11081 / 179670 (6.2%) | −163.6 | −161.6 | 0.29 |
| PGR SRX1012655 | MCF-7 Breast | 244 / 17967 (1.4%) | 9626 / 179670 (5.4%) | −162.9 | −160.9 | 0.25 |
| NR3C1 SRX8520802 | HCC1187 Breast | 285 / 17967 (1.6%) | 10349 / 179670 (5.8%) | −162.8 | −160.8 | 0.28 |
| FOXA1 SRX1961158 | T-47D Breast | 381 / 17967 (2.1%) | 11974 / 179670 (6.7%) | −162.8 | −160.8 | 0.32 |
| AR SRX9109113 | MDA-MB-453 Breast | 768 / 17967 (4.3%) | 17857 / 179670 (9.9%) | −162.6 | −160.6 | 0.43 |
| ESR1 SRX3123829 | MCF-7 Breast | 214 / 17967 (1.2%) | 9065 / 179670 (5.0%) | −162.4 | −160.5 | 0.24 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 422 / 17967 (2.3%) | 12624 / 179670 (7.0%) | −162.4 | −160.4 | 0.33 |
| ARID1A SRX5089382 | MCF-7 Breast | 266 / 17967 (1.5%) | 10000 / 179670 (5.6%) | −162.3 | −160.3 | 0.27 |
| GATA3 SRX6712581 | MCF-7 Breast | 320 / 17967 (1.8%) | 10932 / 179670 (6.1%) | −162.2 | −160.2 | 0.29 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 529 / 17967 (2.9%) | 14296 / 179670 (8.0%) | −162.1 | −160.1 | 0.37 |
| MAU2 SRX15710550 | Fibroblasts Others | 663 / 17967 (3.7%) | 16309 / 179670 (9.1%) | −162.0 | −160.0 | 0.41 |
| FOXA1 SRX5203303 | MCF-7 Breast | 114 / 17967 (0.6%) | 7064 / 179670 (3.9%) | −162.0 | −160.0 | 0.16 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 699 / 17967 (3.9%) | 16827 / 179670 (9.4%) | −161.8 | −159.8 | 0.42 |
| FOXA1 SRX9604647 | LNCAP Prostate | 602 / 17967 (3.4%) | 15392 / 179670 (8.6%) | −161.7 | −159.7 | 0.39 |
| ESR1 SRX2912055 | MCF-7 Breast | 133 / 17967 (0.7%) | 7455 / 179670 (4.1%) | −161.6 | −159.7 | 0.18 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 274 / 17967 (1.5%) | 10121 / 179670 (5.6%) | −161.6 | −159.6 | 0.27 |
| HMG20A SRX2630163 | Hep G2 Liver | 211 / 17967 (1.2%) | 8979 / 179670 (5.0%) | −161.5 | −159.5 | 0.23 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 370 / 17967 (2.1%) | 11742 / 179670 (6.5%) | −161.3 | −159.3 | 0.32 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 341 / 17967 (1.9%) | 11257 / 179670 (6.3%) | −161.3 | −159.3 | 0.30 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 743 / 17967 (4.1%) | 17432 / 179670 (9.7%) | −160.9 | −158.9 | 0.43 |
| ARID1A SRX5089391 | MCF-7 Breast | 209 / 17967 (1.2%) | 8915 / 179670 (5.0%) | −160.6 | −158.6 | 0.23 |
| GFP SRX5417098 | HeLa Uterus | 464 / 17967 (2.6%) | 13224 / 179670 (7.4%) | −160.4 | −158.4 | 0.35 |
| FOXL2 SRX6957477 | KGN Gonad | 411 / 17967 (2.3%) | 12370 / 179670 (6.9%) | −160.1 | −158.2 | 0.33 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 298 / 17967 (1.7%) | 10487 / 179670 (5.8%) | −160.0 | −158.0 | 0.28 |
| ESR1 SRX5323878 | MCF-7 Breast | 396 / 17967 (2.2%) | 12118 / 179670 (6.7%) | −159.8 | −157.8 | 0.33 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 311 / 17967 (1.7%) | 10696 / 179670 (6.0%) | −159.6 | −157.7 | 0.29 |
| EP300 SRX1012648 | MCF-7 Breast | 180 / 17967 (1.0%) | 8334 / 179670 (4.6%) | −159.6 | −157.7 | 0.22 |
| GATA3 SRX5457550 | MCF-7 Breast | 457 / 17967 (2.5%) | 13081 / 179670 (7.3%) | −159.5 | −157.5 | 0.35 |
| FOXA1 SRX3923519 | MCF-7 Breast | 232 / 17967 (1.3%) | 9298 / 179670 (5.2%) | −159.4 | −157.4 | 0.25 |
| GATAD2A SRX2636507 | Hep G2 Liver | 433 / 17967 (2.4%) | 12684 / 179670 (7.1%) | −159.0 | −157.1 | 0.34 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 339 / 17967 (1.9%) | 11146 / 179670 (6.2%) | −158.9 | −157.0 | 0.30 |
| FOXA1 SRX190282 | A549 Lung | 266 / 17967 (1.5%) | 9893 / 179670 (5.5%) | −158.9 | −157.0 | 0.27 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 417 / 17967 (2.3%) | 12419 / 179670 (6.9%) | −158.7 | −156.8 | 0.34 |
| FOXA1 SRX5323845 | MCF-7 Breast | 130 / 17967 (0.7%) | 7308 / 179670 (4.1%) | −158.6 | −156.6 | 0.18 |
| ESR1 SRX1012629 | MCF-7 Breast | 246 / 17967 (1.4%) | 9524 / 179670 (5.3%) | −158.5 | −156.6 | 0.26 |
| ESR1 SRX20282938 | MCF-7 Breast | 322 / 17967 (1.8%) | 10844 / 179670 (6.0%) | −158.4 | −156.5 | 0.30 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 590 / 17967 (3.3%) | 15089 / 179670 (8.4%) | −158.4 | −156.4 | 0.39 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 325 / 17967 (1.8%) | 10892 / 179670 (6.1%) | −158.3 | −156.4 | 0.30 |
| FOXA1 SRX219284 | LNCAP Prostate | 541 / 17967 (3.0%) | 14341 / 179670 (8.0%) | −158.3 | −156.3 | 0.38 |
| EP300 SRX10976215 | A549 Lung | 366 / 17967 (2.0%) | 11572 / 179670 (6.4%) | −158.2 | −156.2 | 0.32 |
| RNF2 SRX18954719 | SCC-25 Others | 545 / 17967 (3.0%) | 14388 / 179670 (8.0%) | −157.9 | −156.0 | 0.38 |
| FOXA1 SRX9604645 | LNCAP Prostate | 566 / 17967 (3.2%) | 14710 / 179670 (8.2%) | −157.9 | −156.0 | 0.38 |
| KAT7 DRX234808 | 293 Kidney | 801 / 17967 (4.5%) | 2385 / 179670 (1.3%) | −157.9 | −155.9 | 3.36 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 260 / 17967 (1.4%) | 9752 / 179670 (5.4%) | −157.8 | −155.8 | 0.27 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 834 / 17967 (4.6%) | 2569 / 179670 (1.4%) | −157.3 | −155.3 | 3.25 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 343 / 17967 (1.9%) | 11157 / 179670 (6.2%) | −157.1 | −155.2 | 0.31 |
| FOXA1 SRX5323829 | T-47D Breast | 213 / 17967 (1.2%) | 8875 / 179670 (4.9%) | −156.8 | −154.9 | 0.24 |
| ESR1 SRX8537723 | MCF-7 Breast | 323 / 17967 (1.8%) | 10811 / 179670 (6.0%) | −156.8 | −154.9 | 0.30 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1396 / 17967 (7.8%) | 26121 / 179670 (14.5%) | −156.8 | −154.8 | 0.53 |
| ESR1 SRX1469949 | MCF-7 Breast | 223 / 17967 (1.2%) | 9054 / 179670 (5.0%) | −156.7 | −154.8 | 0.25 |
| EP300 SRX100540 | SK-N-SH Neural | 589 / 17967 (3.3%) | 15006 / 179670 (8.4%) | −156.6 | −154.6 | 0.39 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 522 / 17967 (2.9%) | 13986 / 179670 (7.8%) | −156.5 | −154.6 | 0.37 |
| ESR1 SRX1012632 | MCF-7 Breast | 194 / 17967 (1.1%) | 8483 / 179670 (4.7%) | −155.6 | −153.7 | 0.23 |
| NR3C1 SRX2609665 | HASM2 Lung | 454 / 17967 (2.5%) | 12899 / 179670 (7.2%) | −155.6 | −153.6 | 0.35 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1399 / 17967 (7.8%) | 26097 / 179670 (14.5%) | −155.4 | −153.5 | 0.54 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 587 / 17967 (3.3%) | 14931 / 179670 (8.3%) | −155.4 | −153.5 | 0.39 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 448 / 17967 (2.5%) | 12793 / 179670 (7.1%) | −155.3 | −153.4 | 0.35 |
| FOS SRX3322636 | MCF-7 Breast | 261 / 17967 (1.5%) | 9691 / 179670 (5.4%) | −155.2 | −153.3 | 0.27 |
| DAXX SRX1021630 | PC-3 Prostate | 412 / 17967 (2.3%) | 12216 / 179670 (6.8%) | −155.2 | −153.3 | 0.34 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 685 / 17967 (3.8%) | 1817 / 179670 (1.0%) | −155.2 | −153.3 | 3.77 |
| RNF2 SRX18954704 | FaDu Others | 973 / 17967 (5.4%) | 20427 / 179670 (11.4%) | −155.1 | −153.2 | 0.48 |
| CEBPB SRX190345 | MCF-7 Breast | 307 / 17967 (1.7%) | 10481 / 179670 (5.8%) | −155.1 | −153.1 | 0.29 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 529 / 17967 (2.9%) | 14041 / 179670 (7.8%) | −155.0 | −153.1 | 0.38 |
| CEBPB SRX2194249 | SUM 159PT Breast | 397 / 17967 (2.2%) | 11957 / 179670 (6.7%) | −154.7 | −152.8 | 0.33 |
| NR3C1 SRX10976921 | A549 Lung | 283 / 17967 (1.6%) | 10052 / 179670 (5.6%) | −154.5 | −152.6 | 0.28 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 492 / 17967 (2.7%) | 13452 / 179670 (7.5%) | −154.5 | −152.5 | 0.37 |
| FOXA1 SRX5323846 | MCF-7 Breast | 139 / 17967 (0.8%) | 7373 / 179670 (4.1%) | −154.4 | −152.5 | 0.19 |
| NANOG SRX10445309 | Neural crest cells Neural | 214 / 17967 (1.2%) | 8812 / 179670 (4.9%) | −154.2 | −152.3 | 0.24 |
| JUNB SRX10119383 | MCF 10A Breast | 277 / 17967 (1.5%) | 9930 / 179670 (5.5%) | −154.1 | −152.2 | 0.28 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 471 / 17967 (2.6%) | 13105 / 179670 (7.3%) | −153.8 | −151.9 | 0.36 |
| FOXA1 SRX5323830 | T-47D Breast | 230 / 17967 (1.3%) | 9090 / 179670 (5.1%) | −153.8 | −151.8 | 0.25 |
| ESR1 SRX4451212 | MCF-7 Breast | 388 / 17967 (2.2%) | 11778 / 179670 (6.6%) | −153.7 | −151.8 | 0.33 |
| SOX5 SRX2636544 | Hep G2 Liver | 406 / 17967 (2.3%) | 12063 / 179670 (6.7%) | −153.5 | −151.6 | 0.34 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 794 / 17967 (4.4%) | 17868 / 179670 (9.9%) | −153.5 | −151.6 | 0.44 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1716 / 17967 (9.6%) | 8205 / 179670 (4.6%) | −153.3 | −151.4 | 2.09 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 263 / 17967 (1.5%) | 9661 / 179670 (5.4%) | −153.3 | −151.4 | 0.27 |
| FOS SRX070879 | HUVEC Cardiovascular | 442 / 17967 (2.5%) | 12621 / 179670 (7.0%) | −153.0 | −151.1 | 0.35 |
| FOXA2 SRX10475773 | Hep G2 Liver | 505 / 17967 (2.8%) | 13597 / 179670 (7.6%) | −153.0 | −151.1 | 0.37 |
| ESR1 SRX2513517 | MCF-7 Breast | 276 / 17967 (1.5%) | 9879 / 179670 (5.5%) | −153.0 | −151.1 | 0.28 |
| FOXA1 SRX3931033 | MCF-7 Breast | 249 / 17967 (1.4%) | 9402 / 179670 (5.2%) | −153.0 | −151.1 | 0.26 |
| ESR1 SRX5323872 | MCF-7 Breast | 407 / 17967 (2.3%) | 12061 / 179670 (6.7%) | −152.9 | −151.0 | 0.34 |
| NFIL3 SRX2630334 | Hep G2 Liver | 325 / 17967 (1.8%) | 10711 / 179670 (6.0%) | −152.8 | −150.9 | 0.30 |
| ESR1 SRX2513521 | MCF-7 Breast | 185 / 17967 (1.0%) | 8219 / 179670 (4.6%) | −152.6 | −150.7 | 0.23 |
| ESR1 SRX11120903 | MCF-7 Breast | 360 / 17967 (2.0%) | 11279 / 179670 (6.3%) | −152.5 | −150.6 | 0.32 |
| TLE3 SRX4815194 | SUM 149PT Breast | 308 / 17967 (1.7%) | 10406 / 179670 (5.8%) | −152.3 | −150.4 | 0.30 |
| NR3C1 SRX19024866 | MCF-7 Breast | 131 / 17967 (0.7%) | 7147 / 179670 (4.0%) | −152.3 | −150.4 | 0.18 |
| ZEB1 SRX13298925 | MCF-7 Breast | 251 / 17967 (1.4%) | 9416 / 179670 (5.2%) | −152.3 | −150.4 | 0.27 |
| VGLL1 SRX18013277 | FULVR Breast | 164 / 17967 (0.9%) | 7806 / 179670 (4.3%) | −152.2 | −150.3 | 0.21 |
| RAD21 SRX150650 | HeLa Uterus | 557 / 17967 (3.1%) | 14360 / 179670 (8.0%) | −152.1 | −150.2 | 0.39 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 369 / 17967 (2.1%) | 11410 / 179670 (6.4%) | −151.9 | −150.0 | 0.32 |
| FOXA1 SRX3923515 | MCF-7 Breast | 223 / 17967 (1.2%) | 8904 / 179670 (5.0%) | −151.8 | −149.9 | 0.25 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 541 / 17967 (3.0%) | 1171 / 179670 (0.7%) | −151.6 | −149.7 | 4.62 |
| EP300 SRX1012644 | MCF-7 Breast | 179 / 17967 (1.0%) | 8071 / 179670 (4.5%) | −151.5 | −149.6 | 0.22 |
| ARID1A SRX5089388 | MCF-7 Breast | 198 / 17967 (1.1%) | 8429 / 179670 (4.7%) | −151.4 | −149.5 | 0.23 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 261 / 17967 (1.5%) | 9557 / 179670 (5.3%) | −151.0 | −149.1 | 0.27 |
| Epitope tags SRX20741925 | Hep G2 Liver | 721 / 17967 (4.0%) | 16725 / 179670 (9.3%) | −151.0 | −149.1 | 0.43 |
| NR3C1 SRX10977372 | A549 Lung | 233 / 17967 (1.3%) | 9052 / 179670 (5.0%) | −150.8 | −148.9 | 0.26 |
| WWTR1 SRX10119368 | MCF 10A Breast | 285 / 17967 (1.6%) | 9963 / 179670 (5.5%) | −150.7 | −148.8 | 0.29 |
| ESR1 SRX2513520 | MCF-7 Breast | 256 / 17967 (1.4%) | 9450 / 179670 (5.3%) | −150.6 | −148.7 | 0.27 |
| GATA3 SRX100559 | T-47D Breast | 461 / 17967 (2.6%) | 12824 / 179670 (7.1%) | −150.4 | −148.5 | 0.36 |
| ZNF219 SRX3230413 | Hep G2 Liver | 719 / 17967 (4.0%) | 16674 / 179670 (9.3%) | −150.3 | −148.4 | 0.43 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 536 / 17967 (3.0%) | 13972 / 179670 (7.8%) | −150.3 | −148.4 | 0.38 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1002 / 17967 (5.6%) | 20617 / 179670 (11.5%) | −150.2 | −148.3 | 0.49 |
| SP1 SRX190358 | HCT 116 Digestive tract | 643 / 17967 (3.6%) | 15559 / 179670 (8.7%) | −150.0 | −148.2 | 0.41 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 677 / 17967 (3.8%) | 16054 / 179670 (8.9%) | −150.0 | −148.1 | 0.42 |
| FOXA1 SRX3931032 | MCF-7 Breast | 229 / 17967 (1.3%) | 8948 / 179670 (5.0%) | −149.9 | −148.0 | 0.26 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 656 / 17967 (3.7%) | 15744 / 179670 (8.8%) | −149.8 | −148.0 | 0.42 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 397 / 17967 (2.2%) | 11787 / 179670 (6.6%) | −149.8 | −147.9 | 0.34 |
| ESR1 SRX792933 | LY2 Breast | 335 / 17967 (1.9%) | 10777 / 179670 (6.0%) | −149.8 | −147.9 | 0.31 |
| FOS SRX150664 | HUVEC Cardiovascular | 562 / 17967 (3.1%) | 14339 / 179670 (8.0%) | −149.6 | −147.7 | 0.39 |
| FOXA1 SRX6860635 | T-47D Breast | 307 / 17967 (1.7%) | 10298 / 179670 (5.7%) | −149.6 | −147.7 | 0.30 |
| Epitope tags SRX5877913 | U2OS Bone | 2243 / 17967 (12.5%) | 36285 / 179670 (20.2%) | −149.5 | −147.6 | 0.62 |
| ESR1 SRX20282959 | MCF-7 Breast | 165 / 17967 (0.9%) | 7744 / 179670 (4.3%) | −149.5 | −147.6 | 0.21 |
| NR3C1 SRX17639413 | A549 Lung | 285 / 17967 (1.6%) | 9923 / 179670 (5.5%) | −149.4 | −147.6 | 0.29 |
| FOXA1 SRX6878604 | LNCAP Prostate | 330 / 17967 (1.8%) | 10679 / 179670 (5.9%) | −149.3 | −147.5 | 0.31 |
| FOXA1 SRX5203307 | MCF-7 Breast | 108 / 17967 (0.6%) | 6578 / 179670 (3.7%) | −149.2 | −147.3 | 0.16 |
| ESR1 SRX5534831 | MCF-7 Breast | 321 / 17967 (1.8%) | 10521 / 179670 (5.9%) | −149.1 | −147.3 | 0.31 |
| ESR1 SRX2881001 | MCF-7 Breast | 224 / 17967 (1.2%) | 8830 / 179670 (4.9%) | −149.0 | −147.1 | 0.25 |
| ESR1 SRX5323877 | MCF-7 Breast | 322 / 17967 (1.8%) | 10533 / 179670 (5.9%) | −149.0 | −147.1 | 0.31 |
| EP300 SRX1012643 | MCF-7 Breast | 141 / 17967 (0.8%) | 7252 / 179670 (4.0%) | −148.9 | −147.0 | 0.19 |
| FOXA1 SRX5203294 | MCF-7 Breast | 106 / 17967 (0.6%) | 6522 / 179670 (3.6%) | −148.7 | −146.9 | 0.16 |
| RXRB SRX2636027 | Hep G2 Liver | 450 / 17967 (2.5%) | 12591 / 179670 (7.0%) | −148.6 | −146.8 | 0.36 |
| NR3C1 SRX2609659 | HASM2 Lung | 495 / 17967 (2.8%) | 13283 / 179670 (7.4%) | −148.6 | −146.7 | 0.37 |
| RNF2 SRX18954702 | FaDu Others | 947 / 17967 (5.3%) | 19789 / 179670 (11.0%) | −148.5 | −146.6 | 0.48 |
| FOXA1 SRX3931056 | MCF-7 Breast | 236 / 17967 (1.3%) | 9029 / 179670 (5.0%) | −148.4 | −146.6 | 0.26 |
| NR3C1 SRX2609662 | HASM2 Lung | 509 / 17967 (2.8%) | 13485 / 179670 (7.5%) | −148.2 | −146.3 | 0.38 |
| NR3C1 SRX10977357 | A549 Lung | 255 / 17967 (1.4%) | 9347 / 179670 (5.2%) | −147.9 | −146.0 | 0.27 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 287 / 17967 (1.6%) | 9897 / 179670 (5.5%) | −147.7 | −145.8 | 0.29 |
| EP300 SRX100544 | Hep G2 Liver | 318 / 17967 (1.8%) | 10417 / 179670 (5.8%) | −147.6 | −145.7 | 0.31 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 229 / 17967 (1.3%) | 8868 / 179670 (4.9%) | −147.2 | −145.3 | 0.26 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 313 / 17967 (1.7%) | 10318 / 179670 (5.7%) | −147.1 | −145.3 | 0.30 |
| FOXA1 SRX1161205 | T-47D Breast | 216 / 17967 (1.2%) | 8624 / 179670 (4.8%) | −147.0 | −145.1 | 0.25 |
| RELA SRX7054617 | HAEC Cardiovascular | 513 / 17967 (2.9%) | 13498 / 179670 (7.5%) | −146.9 | −145.1 | 0.38 |
| FOSL2 SRX10475315 | Hep G2 Liver | 467 / 17967 (2.6%) | 12789 / 179670 (7.1%) | −146.8 | −145.0 | 0.37 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 418 / 17967 (2.3%) | 12019 / 179670 (6.7%) | −146.8 | −145.0 | 0.35 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 311 / 17967 (1.7%) | 10276 / 179670 (5.7%) | −146.7 | −144.9 | 0.30 |
| FOXA1 SRX1447316 | MCF-7 Breast | 167 / 17967 (0.9%) | 7701 / 179670 (4.3%) | −146.7 | −144.8 | 0.22 |
| TP53 SRX19538272 | U2OS Bone | 539 / 17967 (3.0%) | 1203 / 179670 (0.7%) | −146.6 | −144.8 | 4.48 |
| ESR1 SRX330068 | MCF-7 Breast | 194 / 17967 (1.1%) | 8204 / 179670 (4.6%) | −146.5 | −144.6 | 0.24 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 417 / 17967 (2.3%) | 11991 / 179670 (6.7%) | −146.4 | −144.6 | 0.35 |
| TRP47 SRX4548329 | THP-1 Blood | 2583 / 17967 (14.4%) | 14797 / 179670 (8.2%) | −146.4 | −144.5 | 1.75 |
| SMC1A SRX1013334 | HuCCT1 Liver | 1196 / 17967 (6.7%) | 23030 / 179670 (12.8%) | −146.1 | −144.3 | 0.52 |
| CEBPA SRX4705113 | MOLM-13 Blood | 978 / 17967 (5.4%) | 20109 / 179670 (11.2%) | −146.0 | −144.1 | 0.49 |
| JUNB SRX10119384 | MCF 10A Breast | 257 / 17967 (1.4%) | 9322 / 179670 (5.2%) | −145.9 | −144.0 | 0.28 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 613 / 17967 (3.4%) | 14945 / 179670 (8.3%) | −145.5 | −143.6 | 0.41 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 283 / 17967 (1.6%) | 9756 / 179670 (5.4%) | −145.4 | −143.6 | 0.29 |
| FOXA1 SRX3923511 | MCF-7 Breast | 148 / 17967 (0.8%) | 7289 / 179670 (4.1%) | −145.3 | −143.4 | 0.20 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 364 / 17967 (2.0%) | 11102 / 179670 (6.2%) | −145.2 | −143.4 | 0.33 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1189 / 17967 (6.6%) | 22893 / 179670 (12.7%) | −145.1 | −143.3 | 0.52 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 734 / 17967 (4.1%) | 2180 / 179670 (1.2%) | −145.0 | −143.1 | 3.37 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 298 / 17967 (1.7%) | 9995 / 179670 (5.6%) | −144.9 | −143.1 | 0.30 |
| ESR1 SRX1469951 | MCF-7 Breast | 215 / 17967 (1.2%) | 8539 / 179670 (4.8%) | −144.8 | −143.0 | 0.25 |
| ZEB1 SRX13298924 | MCF-7 Breast | 202 / 17967 (1.1%) | 8299 / 179670 (4.6%) | −144.7 | −142.8 | 0.24 |
| FOXA3 SRX2630190 | Hep G2 Liver | 356 / 17967 (2.0%) | 10947 / 179670 (6.1%) | −144.5 | −142.7 | 0.33 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 580 / 17967 (3.2%) | 14399 / 179670 (8.0%) | −144.1 | −142.2 | 0.40 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 148 / 17967 (0.8%) | 7239 / 179670 (4.0%) | −143.6 | −141.8 | 0.20 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 756 / 17967 (4.2%) | 2314 / 179670 (1.3%) | −143.6 | −141.7 | 3.27 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 162 / 17967 (0.9%) | 7509 / 179670 (4.2%) | −143.5 | −141.7 | 0.22 |
| ESR1 SRX1012633 | MCF-7 Breast | 221 / 17967 (1.2%) | 8603 / 179670 (4.8%) | −143.4 | −141.6 | 0.26 |
| KMT2C SRX1787675 | MCF-7 Breast | 379 / 17967 (2.1%) | 11273 / 179670 (6.3%) | −143.3 | −141.5 | 0.34 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 277 / 17967 (1.5%) | 9574 / 179670 (5.3%) | −143.1 | −141.2 | 0.29 |
| EP300 SRX717859 | HeLa Uterus | 220 / 17967 (1.2%) | 8573 / 179670 (4.8%) | −143.1 | −141.2 | 0.26 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 129 / 17967 (0.7%) | 6840 / 179670 (3.8%) | −143.1 | −141.2 | 0.19 |
| FOXA1 SRX2642368 | VCaP Prostate | 527 / 17967 (2.9%) | 13566 / 179670 (7.6%) | −143.0 | −141.1 | 0.39 |
| EP300 SRX10976625 | A549 Lung | 248 / 17967 (1.4%) | 9066 / 179670 (5.0%) | −142.9 | −141.0 | 0.27 |
| NR3C1 SRX19024870 | MCF-7 Breast | 137 / 17967 (0.8%) | 6997 / 179670 (3.9%) | −142.9 | −141.0 | 0.20 |
Showing first 500 of 18119 rows.